SELECTED PUBLICATIONS

•  Kleczko, E.K., Marsh, K.H., Tyler, L.C., Furgeson, S.B., Bullock, B.L., Altmann, C.J., Miyazaki, M., Gitomer, B.Y., Harris, P.C., Weiser-Evans, M.C. and Chonchol, M.B., 2018. CD8+ T cells modulate autosomal dominant polycystic kidney disease progression. Kidney international, 94(6), pp.1127-1140. https://www.ncbi.nlm.nih.gov/pubmed/30249452

• Li, H.Y., McSharry, M., Walker, D., Johnson, A., Kwak, J., Bullock, B., Neuwelt, A., Poczobutt, J.M., Sippel, T.R., Keith, R.L. and Weiser-Evans, M.C., 2018. Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II. OncoImmunology, 7(5), p.e1423182. https://www.ncbi.nlm.nih.gov/pubmed/29721380

​

• Kimball, A.K., Oko, L.M., Bullock, B.L., Nemenoff, R.A., van Dyk, L.F. and Clambey, E.T., 2018. A beginner’s guide to analyzing and visualizing mass cytometry data. The Journal of Immunology, 200(1), pp.3-22. https://www.ncbi.nlm.nih.gov/pubmed/29255085

• Kwak, J.W., Laskowski, J., Li, H.Y., McSharry, M.V., Sippel, T.R., Bullock, B.L., Johnson, A.M., Poczobutt, J.M., Neuwelt, A.J., Malkoski, S.P. and Weiser-Evans, M.C., 2018. Complement activation via a C3a receptor pathway alters CD4+ T lymphocytes and mediates lung cancer progression. Cancer research, 78(1), pp.143-156. https://www.ncbi.nlm.nih.gov/pubmed/29118090

• Li, H.Y., McSharry, M., Bullock, B., Nguyen, T.T., Kwak, J., Poczobutt, J.M., Sippel, T.R., Heasley, L.E., Weiser-Evans, M.C., Clambey, E.T. and Nemenoff, R.A., 2017. The tumor microenvironment regulates sensitivity of murine lung tumors to PD-1/PD-L1 antibody blockade. Cancer immunology research, 5(9), pp.767-777. https://www.ncbi.nlm.nih.gov/pubmed/28819064

• Poczobutt, J.M., De, S., Yadav, V.K., Nguyen, T.T., Li, H., Sippel, T.R., Weiser-Evans, M.C. and Nemenoff, R.A., 2016. Expression profiling of macrophages reveals multiple populations with distinct biological roles in an immunocompetent orthotopic model of lung cancer. The Journal of Immunology, 196(6), pp.2847-2859. https://www.ncbi.nlm.nih.gov/pubmed/26873985

• Poczobutt, J.M., Nguyen, T.T., Hanson, D., Li, H., Sippel, T.R., Weiser-Evans, M.C., Gijon, M., Murphy, R.C. and Nemenoff, R.A., 2016. Deletion of 5-lipoxygenase in the tumor microenvironment promotes lung cancer progression and metastasis through regulating T cell recruitment. The Journal of Immunology, 196(2), pp.891-901. https://www.ncbi.nlm.nih.gov/pubmed/26663781

• Poczobutt, J.M., Gijon, M., Amin, J., Hanson, D., Li, H., Walker, D., Weiser-Evans, M., Lu, X., Murphy, R.C. and Nemenoff, R.A., 2013. Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment. PloS one, 8(11), p.e79633. https://www.ncbi.nlm.nih.gov/pubmed/24244531

• Li, H., Weiser-Evans, M. and Nemenoff, R., 2012. Anti-and protumorigenic effects of PPARγ in lung cancer progression: a double-edged sword. PPAR research, 2012. https://www.ncbi.nlm.nih.gov/pubmed/22934105

• Nemenoff, R., 2012. Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis. Oncoimmunology, 1(3), pp.403-404. https://www.ncbi.nlm.nih.gov/pubmed/22737631

• Li, H., Sorenson, A.L., Poczobutt, J., Amin, J., Joyal, T., Sullivan, T., Crossno Jr, J.T., Weiser-Evans, M.C. and Nemenoff, R.A., 2011. Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis. PloS one, 6(12), p.e28133. https://www.ncbi.nlm.nih.gov/pubmed/22145026

• Weiser-Evans, M.C., Wang, X.Q., Amin, J., Van Putten, V., Choudhary, R., Winn, R.A., Scheinman, R., Simpson, P., Geraci, M.W. and Nemenoff, R.A., 2009. Depletion of cytosolic phospholipase A2 in bone marrow–derived macrophages protects against lung cancer progression and metastasis. Cancer research, 69(5), pp.1733-1738. https://www.ncbi.nlm.nih.gov/pubmed/19208832

• Wang, X.Q., Li, H., Van Putten, V., Winn, R.A., Heasley, L.E. and Nemenoff, R.A., 2009. Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9. Molecular biology of the cell, 20(3), pp.791-800. https://www.ncbi.nlm.nih.gov/pubmed/19037103

• Bren-Mattison, Y., Meyer, A.M., Van Putten, V., Li, H., Kuhn, K., Stearman, R., Weiser-Evans, M., Winn, R.A., Heasley, L.E. and Nemenoff, R.A., 2008. Antitumorigenic effects of peroxisome proliferator-activated receptor-γ in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-κB. Molecular pharmacology, 73(3), pp.709-717. https://www.ncbi.nlm.nih.gov/pubmed/18055759